ACC 2014:哪些严重二尖瓣返流患者适宜早期手术治疗?

2014-04-01 小田 译 医学论坛网

2014年美国心脏病学会年会(ACC 2014)公布的一项研究表明,在年龄≥50岁的严重二尖瓣返流(MR)但无症状的患者中,与保守治疗相比,早期手术与其心血管死亡和心脏事件长期减少显著相关。研究论文3月30日在线发表于《美国心脏病学杂志》(J Am Coll Cardiol)。 研究共纳入610例严重MR但无症状的序贯患者,前瞻性评估保留的左心室功能。接受早期手术和常规治疗的病例数分别为235例

2014年美国心脏病学会年会(ACC 2014)公布的一项研究表明,在年龄≥50岁的严重二尖瓣返流(MR)但无症状的患者中,与保守治疗相比,早期手术与其心血管死亡和心脏事件长期减少显著相关。研究论文3月30日在线发表于《美国心脏病学杂志》(J Am Coll Cardiol)。

研究共纳入610例严重MR但无症状的序贯患者,前瞻性评估保留的左心室功能。接受早期手术和常规治疗的病例数分别为235例和375例。推断出207对相匹配队列的倾向性评分。在这些队列中对比两种治疗方法的总体死亡率、心血管死亡、和心脏事件(手术死亡、心脏死亡、重复手术和因心力衰竭紧急入院)。

结果显示,在207对倾向性评分相匹配的队列中,与常规治疗组相比,早期手术组患者的心脏死亡和心脏事件风险均校低,P值分别为0.03和0.002,危险比(HR)分别为0.109和0.216。Cox比例风险模型分析显示,与常规治疗组相比,行早期手术治疗、年龄≥50岁患者心脏事件风险显著较低(HR 0.221,P= 0.002),但在年龄<50岁的患者中并无显著差异(P= 0.20)。

原始出处:

Duk-Hyun Kang, Sung-Ji Park, Byung Joo Sun, Eun Jeong Cho, Dae-Hee Kim, Sung-Cheol Yun, Jong-Min Song, Seung Woo Park, Cheol-Hyun Chung, Jae-Kwan Song, Jae-Won Lee, Pyo-Won Park.Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis.JACC Mar 30 2014

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1290545, encodeId=1d531290545ae, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324906, encodeId=a22a1324906c2, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418740, encodeId=031a1418e4009, content=<a href='/topic/show?id=e5be23919cf' target=_blank style='color:#2F92EE;'>#二尖瓣返流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23919, encryptionId=e5be23919cf, topicName=二尖瓣返流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad623409629, createdName=kksonne, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463136, encodeId=62ce1463136a8, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1290545, encodeId=1d531290545ae, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324906, encodeId=a22a1324906c2, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418740, encodeId=031a1418e4009, content=<a href='/topic/show?id=e5be23919cf' target=_blank style='color:#2F92EE;'>#二尖瓣返流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23919, encryptionId=e5be23919cf, topicName=二尖瓣返流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad623409629, createdName=kksonne, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463136, encodeId=62ce1463136a8, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1290545, encodeId=1d531290545ae, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324906, encodeId=a22a1324906c2, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418740, encodeId=031a1418e4009, content=<a href='/topic/show?id=e5be23919cf' target=_blank style='color:#2F92EE;'>#二尖瓣返流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23919, encryptionId=e5be23919cf, topicName=二尖瓣返流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad623409629, createdName=kksonne, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463136, encodeId=62ce1463136a8, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1290545, encodeId=1d531290545ae, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324906, encodeId=a22a1324906c2, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418740, encodeId=031a1418e4009, content=<a href='/topic/show?id=e5be23919cf' target=_blank style='color:#2F92EE;'>#二尖瓣返流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23919, encryptionId=e5be23919cf, topicName=二尖瓣返流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad623409629, createdName=kksonne, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463136, encodeId=62ce1463136a8, content=<a href='/topic/show?id=cff92389310' target=_blank style='color:#2F92EE;'>#二尖瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23893, encryptionId=cff92389310, topicName=二尖瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb26536308, createdName=wwzzly, createdTime=Thu Apr 03 00:25:00 CST 2014, time=2014-04-03, status=1, ipAttribution=)]
    2014-04-03 wwzzly